Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Analyst Recommendations on ABBOTT LABORATORIES
08/27ABBOTT LABORATORIES : Goldman Sachs gives a Sell rating
MD
08/27Abbott Shares Rise 8% on FDA Approval for Covid-19 Rapid Test
DJ
2018AbbVie CFO Chase to retire by mid-year 2019
RE
2017Germany's Merck hires JP Morgan to sell consumer health
RE
2017Siemens to update medical scanner software to deal with security bugs
RE
2015Cardinal to buy J&J vascular technology unit Cordis for $1.9 billion
RE
2014Exclusive - Hospira talks with Danone on $5 billion tax inversion deal stall
RE
2014Abbott to buy Latin American drugmaker CFR in $2.9 billion deal
RE
2014Abbott to buy Latin American drugmaker CFR in $2.9 billion deal
RE
2014EXCLUSIVE : Abbott taps Morgan Stanley to sell mature products - sources
RE
2014Danone considers sale of tube feeding products arm - sources
RE
2014EXCLUSIVE : Danone considers sale of tube feeding products arm - sources
RE
2014EXCLUSIVE : Danone considers sale of tube feeding products arm - sources
RE
2013Insight - Profit bonanza eludes companies chasing obesity business
RE
2013Analysis - Bayer immune to pharma's breakup bug?
RE
2013Bayer immune to pharma's breakup bug?
RE
2013Fast-growing Humira extends domination of AbbVie
RE
2013ABBOTT LABORATORIES : Abbott profit beats forecast, nutritional products strong
RE
2013Abbott to buy cataract laser, leg stent businesses
RE
2013Ahead of reform, medical care slowdown hits companies
RE
2013Analysis - Ahead of reform, medical care slowdown hits U.S. companies
RE
2013ABBOTT LABORATORIES : Abbott results bode well for spun-off AbbVie
RE
2012Sales stumbles raise fresh worry for corporate America
RE
2009ABBOTT LABS : Abbott loses sales momentum
RE
2009ABBOTT LABS : Abbott enters eye arena with $1.4 billion AMO deal
RE
Upcoming event on ABBOTT LABORATORIES